DSGN vs PH · $214.0M cap vs P/E 28, rev $19.85B
Design Therapeutics Inc (DSGN) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported DSGN revenue for 2025-09-30 was $0. Net income was -$53.8M. DSGN currently screens at market cap $214.0M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
DSGN currently screens at market cap $214.0M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the DSGN and PH stock pages for the full models.
Not investment advice.